Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IRICoR
Montreal, Quebec, Canadairicor.ca ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
IRICoR accelerates the translation of academic discoveries into new therapies primarily in oncology, immunotherapy, and rare diseases. It has enabled multiple programs to reach proof-of-concept stages—such as off-the-shelf immunotherapies targeting shared tumor antigens—and supports both small molecule and cell therapy approaches. Clinical results are typically reported by its spin-offs or licensees rather than directly under the IRICoR name.
- Therapeutic areas
- OncologyImmunologyRare DiseasesHematologyOther
- Modalities
- Small moleculeCell therapyBiologicImmunotherapyPeptides
- Industry
- Academic Hospital/University/Research
02
Partnerships
Epitopea – collaboration on tumor antigen discovery/immunotherapiesMedigene – joint analyses of novel cancer antigens with University of MontrealMultiple biopharma partners via licensing/commercialization dealsExCellTheraRejuvenRx
Beyond the preview
Go deeper on IRICoR.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IRICoR.